Larry WeinerVP Pharmaceutical Development & Manufacturing (CMC) at Enzyvant Therapeutics
Larry Weiner is a high energy, technical team leader with a 30-year record of motivating people and achieving results in the biopharmaceutical industry. As the Vice President of Pharmaceutical Development and Manufacturing at Enzyvant Therapeutics, Larry recently played a key role in securing FDA commercial approval for a tissue based regenerative medicine product. Immediately prior to Enzyvant Therapeutics, Larry was the Vice President of Technical Operations & CMC at Unum Therapeutics. Other experience includes engineering, program management, process development, and manufacturing leadership roles at Biogen, Sunflower Therapeutics, MassBiologics, Pfizer, Serono, Indigo Ag, and Amgen. He has led and supported cell therapy, gene therapy, biologics, oligonucleotides, tissue therapy, blood fraction & vaccines strategy development, cGMP operations, and regulatory inspections. Larry has a Bachelor of Science in Chemical Engineering from Tufts University, an MBA from Babson College, and a Masters in Bioengineering from Tufts University.